SCHEMBL21889129

SCHEMBL21889129

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1cc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)c(-n2c3ccc(C)cc3c3cc(C)ccc32)cc1-c1nc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.42
PSMB5 P28074 1/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ADORA3 P0DMS8 3/20 0.40
NLRP3 Q96P20 1/20 0.40
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
RECQL P46063 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21838735 0.92 MEN1 (0.39) L3MBTL1PSMB5MEN1KMT2AADORA3
SCHEMBL21375537 0.91 TDO2 (0.40) L3MBTL1PSMB5MEN1KMT2AADORA3
SCHEMBL20648349 0.91 TDO2 (0.40) L3MBTL1PSMB5MEN1KMT2AADORA3
SCHEMBL19942749 0.90 CYP1A2 (0.40) L3MBTL1MEN1KMT2AADORA2AADORA1
SCHEMBL20110481 0.90 L3MBTL1 (0.41) L3MBTL1PSMB5MEN1KMT2AADORA3
SCHEMBL20110552 0.90 L3MBTL1 (0.41) L3MBTL1PSMB5MEN1KMT2AADORA3
SCHEMBL21889131 0.90 KDM4E (0.47) L3MBTL1PSMB5MEN1KMT2ANLRP3
SCHEMBL24124494 0.88 ADORA3 (0.38) L3MBTL1PSMB5MEN1KMT2AADORA3
SCHEMBL20927938 0.88 L3MBTL1 (0.37) L3MBTL1PSMB5MEN1KMT2AADORA3
SCHEMBL27440836 0.88 ADORA3 (0.38) L3MBTL1MEN1KMT2AADORA3NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584739-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-02-21 US disclosed
US-20200115364-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115364-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, CLTB, CYBA L3MBTL1 575/4885PSMB5 2846/4885MEN1 3395/4885
US-11584739-B2 Composition of matter for use in organic light-emitting diodes CRY2, CLTB, CYBA L3MBTL1 575/4885PSMB5 2846/4885MEN1 3395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.